Synthesis and antiprotozoal activity of β-carboline-(piperazinyl)-1,3,5-triazine hybrids
Key Points
The hybrids show notable antiprotozoal activity against target protozoa, highlighting their potential use as drug candidates.
In vitro tests revealed that specific hybrids exhibited up to 85% inhibition of protozoal growth, a promising result for drug development.
Synthesis involved combining β-carboline with piperazinyl and triazine, resulting in novel chemical compounds that could treat infections.
These findings suggest that further exploration of these hybrids may lead to effective treatments for protozoan infections, potentially impacting public health.